A. Lim

发表

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.

S. Jagannath, S. Lonial, A. Oriol, 2019, The Lancet. Haematology.

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft

L. Churilov, S. Hunt, A. Grigg, 2021, Bone Marrow Transplantation.

Treatment practice and outcomes in FLT3-mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals

A. Wei, S. Ting, A. Schwarer, 2019, Leukemia & lymphoma.

Hodgkin lymphoma, allogeneic transplant and the graft-versus-tumor effect: size does matter

D. Ritchie, A. Lim, 2014, Leukemia & lymphoma.

Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorption

D. Ritchie, A. Bajel, R. Ramanan, 2020, Bone Marrow Transplantation.

Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation

J. Szer, M. Tacey, D. Ritchie, 2017, Bone Marrow Transplantation.

High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation

J. Szer, I. Lewis, J. Storek, 2013 .

Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis

J. Szer, I. Lewis, J. Storek, 2015, Bone Marrow Transplantation.

Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse

J. Szer, I. Lewis, A. M. Johnston, 2018, Internal medicine journal.

Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation.

Ashley P Ng, J. Szer, M. Tacey, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.

J. Szer, M. Tacey, D. Ritchie, 2017, Bone marrow transplantation.

Validating the Allogeneic Stem Cell Transplantation Disease Risk Index: Sample Size, Follow-up, and Local Data Are Important

J. Szer, A. Roberts, D. Ritchie, 2015, Transplantation.

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Ashley P Ng, J. Szer, M. Tacey, 2013 .

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis

A. Oriol, P. Moreau, T. Facon, 2021, Hematological oncology.

Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft‐versus‐host disease prophylaxis following allogeneic haemopoietic cell transplantation

J. Szer, A. Bajel, R. Barmanray, 2022, Internal medicine journal.

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia – a Multicentre Australian Experience: Prognostic Factors for Survival and Relapse

J. Szer, D. Curtis, D. Ritchie, 2014 .